Teladoc Health

TDOC

Market cap $934M

Teladoc Health Inc (NYSE: TDOC) posted upbeat results for the fourth quarter on Wednesday.

TDOC posts narrower-than-expected Q4 loss, topping revenue estimates as international and Integrated Care strength offset BetterHelp weakness.

Teladoc Health (NYSE: TDOC) shares are up on Thursday following the company's latest earnings report, which highlighted a mix of revenue changes across its segments.

Although the revenue and EPS for Teladoc (TDOC) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Teladoc Health, Inc. (TDOC) Q4 2025 Earnings Call Transcript

NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended December 31, 2025 (“Fourth Quarter 2025”) and full year ended December 31, 2025 (“Full Year 2025”). Unless otherwise noted, percentage and other changes are relative to the three months ended December 31, 2024 (“Fourth Quarter 2024”) and full year ended December 31, 2024 (“Full Year 2024”).

Get a deeper insight into the potential performance of Teladoc (TDOC) for the quarter ended December 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

Teladoc Health's shares have been crushed over the past five years. The company has sought to turn things around, but with little success so far.

TDOC heads into Q4 earnings with an improving loss outlook and rising Integrated Care EBITDA, but BetterHelp declines may weigh on revenues.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.